In contrast, N-acetylcysteine, an antioxidant currently used as a therapeutic strategy for ETHE1 deficiency, had no effect on superoxide levels in ETHE1-4 (Fig. 7F). The gene discussed is ETHE1; the disease is hyperinsulinemic hypoglycemia, familial, 4.